UPClytics
View all cases

UPC CFI 106/2026

Jan 12, 2026·EP2493466: NOVEL ANTITUMORAL USE OF CABAZITAXEL

Case details
Status
Case Closed
Action
Other
Category
Other Procedural
Division
Munich LD
Technology
Pharmaceutical & Medical
Language
English
Documents
Document titleDatePublic
action.publishOrderDecision.case2026-02-23Not public
action.phaseChange.caseClose2026-02-13Not public
action.issueDecision.decision2026-02-13Not public
Decision2026-02-13Public
Receipt2026-02-09Not public
Cover sheet2026-02-09Not public
Document2026-02-09Not public
action.communication.general2026-02-03Not public
Receipt2026-02-02Not public
Cover sheet2026-02-02Not public
Other document Respondent2026-02-02Not public
action.communication.general2026-01-16Not public
Receipt2026-01-12Not public
Cover sheet2026-01-12Not public
Exhibit document Applicant2026-01-12Not public
Exhibit document Applicant2026-01-12Not public
Exhibit document Applicant2026-01-12Not public
Exhibit document Applicant2026-01-12Not public
Application document Applicant2026-01-12Not public